These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37380452)

  • 1. Irreversible Intrathecal Chemotherapy-induced Myelopathy in a Patient with Diffuse Large B-cell Lymphoma.
    Hirakawa Y; Kitao A; Watanabe M; Matsumoto S; Komaki R; Sakai R; Morimoto K; Yakushijin K; Minami H
    Intern Med; 2024 Feb; 63(4):547-551. PubMed ID: 37380452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literature.
    Alsdorf WH; Schmitz M; Schieferdecker A; Dierlamm J; Bokemeyer C; Binder M
    J Oncol Pharm Pract; 2016 Jun; 22(3):523-7. PubMed ID: 25655468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-induced subacute myelopathy: a serious but treatable complication.
    Miyoshi T; Kondo T; Nishikori M; Kitawaki T; Kobayashi K; Fujimoto M; Yoshinaga N; Oka S; Asagoe K; Imashuku S; Takaori-Kondo A
    J Clin Exp Hematop; 2023; 63(4):251-256. PubMed ID: 38148015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate myelopathy after intrathecal chemotherapy: a case report.
    Murata KY; Maeba A; Yamanegi M; Nakanishi I; Ito H
    J Med Case Rep; 2015 Jun; 9():135. PubMed ID: 26055509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive myelopathy mimicking subacute combined degeneration after intrathecal chemotherapy.
    Yi Y; Kang HJ; Shin HY; Kim K
    J Child Neurol; 2015 Feb; 30(2):246-9. PubMed ID: 24659737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelopathy due to intrathecal chemotherapy: report of six cases.
    Bay A; Oner AF; Etlik O; Yilmaz C; Caksen H
    J Pediatr Hematol Oncol; 2005 May; 27(5):270-2. PubMed ID: 15891563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
    Pinnix CC; Chi L; Jabbour EJ; Milgrom SA; Smith GL; Daver N; Garg N; Cykowski MD; Fuller G; Cachia D; Kamiya-Matsuoka C; Woodman K; Dinardo C; Jain N; Kadia TM; Pemmaraju N; Ohanian M; Konopleva M; Kantarjian HM; Dabaja BS
    Am J Hematol; 2017 Feb; 92(2):155-160. PubMed ID: 27874212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation.
    Dornbos D; Elder JB; Otero JJ; Baiocchi RA; Slone HW; Puduvalli VK; Giglio P
    World Neurosurg; 2019 Aug; 128():381-384. PubMed ID: 31128312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelopathy associated with intrathecal methotrexate.
    Rodrigues PGB; Lima TT; Duarte FB; Nóbrega PR
    Pract Neurol; 2022 Apr; 22(2):141-144. PubMed ID: 34716225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
    Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
    J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal methotrexate induced myelopathy, rare yet serious complication: A case report and review of the literature.
    Bidikian AH; Bazarbachi A; Hourani R; El-Cheikh J; Abou Dalle I
    Curr Res Transl Med; 2021 Jul; 69(3):103296. PubMed ID: 34139603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma presenting with central pontine myelinolysis: a case report.
    Kawata E; Isa R; Yamaguchi J; Tanba K; Tsutsumi Y; Nagakane Y; Uchiyama H; Akaogi T; Kobayashi Y; Uoshima N
    J Med Case Rep; 2015 Jun; 9():131. PubMed ID: 26044457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma].
    Teramura Y; Kameda K; Kanda J; Gomyo A; Hayakawa J; Akahoshi Y; Komiya Y; Harada N; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Wada H; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kako S; Kanda Y
    Rinsho Ketsueki; 2016 May; 57(5):597-601. PubMed ID: 27263784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
    Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
    Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
    Tomita N; Takasaki H; Ishiyama Y; Kishimoto K; Ishibashi D; Koyama S; Ishii Y; Takahashi H; Numata A; Watanabe R; Tachibana T; Ohshima R; Hagihara M; Hashimoto C; Takemura S; Taguchi J; Fujimaki K; Sakai R; Motomura S; Ishigatsubo Y
    Leuk Lymphoma; 2015 Mar; 56(3):725-9. PubMed ID: 24913502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
    Kansara R
    Curr Treat Options Oncol; 2018 Sep; 19(11):52. PubMed ID: 30203318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord.
    Gosavi T; Diong CP; Lim SH
    J Clin Neurosci; 2013 Jul; 20(7):1025-6. PubMed ID: 23647709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.
    Wilson WH; Bromberg JE; Stetler-Stevenson M; Steinberg SM; Martin-Martin L; Muñiz C; Sancho JM; Caballero MD; Davidis MA; Brooimans RA; Sanchez-Gonzalez B; Salar A; González-Barca E; Ribera JM; Shovlin M; Filie A; Dunleavy K; Mehrling T; Spina M; Orfao A
    Haematologica; 2014 Jul; 99(7):1228-35. PubMed ID: 24727817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.
    Lee S; Yamauchi T; Kinoshita K; Imamura S; Kamiya K
    J Clin Exp Hematop; 2017 Oct; 57(2):64-68. PubMed ID: 28883219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.